Vitrakvi

Albertsons logo
Albertsons
$43,916.71
Walmart logo
Walmart
$44,170.00
Walgreens logo
Walgreens
$44,170.99
Show this card to your pharmacist

Vitrakvi Savings card

$43,916.71

BIN
019876
ID
LH0B70FCFC
PCN
CHIPPO
GRP
LHX

Print or send this coupon to your phone

About Vitrakvi

Drug Details

Larotrectinib is a medication used in the treatment of cancer. It functions by inhibiting the growth and proliferation of cancer cells.

Price history for Vitrakvi

60 Capsules, 100MG

Average retail price for Vitrakvi

Average SaveHealth price for Vitrakvi

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Related Prescriptions

Vitrakvi dosage forms

DosageQuantityPrice fromPer unit
25MG60 Capsules$14,644.03$244.07
100MG60 Capsules$43,916.71$731.95

Vitrakvi FAQs

Vitrakvi (larotrectinib) is used for the treatment of solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. It is not specific to a particular type of cancer but is used for tumors with this specific genetic feature, regardless of the tumor's location in the body.

The cost of Vitrakvi (larotrectinib) can vary significantly based on factors such as insurance coverage, pharmacy location, and dosage. Without insurance, the price can be quite high, often exceeding several thousand dollars for a month's supply. Patients are encouraged to check with their insurance provider for coverage details and explore patient assistance programs offered by the manufacturer to potentially reduce out-of-pocket expenses.

Coverage for Vitrakvi (larotrectinib) under Medicare can vary depending on the specific Medicare plan. Generally, Medicare Part D or Medicare Advantage plans with prescription drug coverage may cover Vitrakvi. It is important for individuals to check with their specific plan provider to confirm coverage details, including any prior authorization requirements or out-of-pocket costs.

Vitrakvi, also known as larotrectinib, works by targeting and inhibiting a specific protein called TRK (tropomyosin receptor kinase). This protein is involved in the growth and survival of cancer cells. Vitrakvi is designed to block the activity of TRK, thereby preventing the cancer cells from growing and spreading. It is used to treat solid tumors that have a specific genetic alteration known as an NTRK gene fusion, regardless of the tumor's location in the body.

The cost of Vitrakvi (larotrectinib) in the United States can vary depending on factors such as insurance coverage, pharmacy, and location. As of the latest information, the list price for Vitrakvi can be quite high, often exceeding several thousand dollars for a month's supply. Patients are encouraged to check with their insurance provider and pharmacy for specific pricing and potential financial assistance programs that may be available.

Read All FAQs